{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:03:54Z","timestamp":1758398634910,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Porcine edema disease (ED) is an enterotoxaemia that frequently occurs in 4\u201312\u00a0week-old piglets and results in high mortality. ED is caused by Shiga toxin 2e (Stx2e), produced by host-adapted Shiga toxin-producing <jats:italic>Escherichia coli<\/jats:italic> (STEC) strains. We constructed a recombinant protein in which the B subunit of Stx2e (Stx2eB) was linked to Cartilage Oligomeric Matrix Protein (COMP)\u2019s pentameric domain to enhance antigenicity to induce neutralizing antibodies against Stx2e. We evaluated the efficacy of this antigen as a vaccine on the farm where ED had occurred. The suckling piglets were divided into two groups. The pigs in the vaccinated group were intramuscularly immunized with the vaccine containing 30\u00a0\u00b5g\/head of Stx2eB-COMP at 1 and 4\u00a0weeks of age. The control pigs were injected with saline instead of the vaccine. The neutralizing antibody titer to Stx2e, mortality, clinical score, and body weight was evaluated up to 11\u00a0weeks after the first vaccination. In the vaccinated group, the Stx2e neutralizing antibody was detected 3\u00a0weeks after the first vaccination, its titer increased during the following weeks. The antibody was not detected in the control group during the test period. The STEC gene was detected in both groups during the test period, but a typical ED was observed only in control pigs; the mortality and clinical score were significantly lower in the vaccinated group than in the control group. These data indicate that the pentameric B subunit vaccine is effective for preventing ED and offers a promising tool for pig health control.<\/jats:p>","DOI":"10.1186\/s13567-023-01161-1","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T13:04:03Z","timestamp":1679922243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Induction of antitoxic antibody and preventive effect against porcine edema disease by the pentameric Stx2eB subunit vaccine"],"prefix":"10.1186","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-4902","authenticated-orcid":false,"given":"Masaya","family":"Yoshimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youko","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Yonemitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Suenaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Waki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"1161_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.toxicon.2018.04.019","volume":"148","author":"NA Casanova","year":"2018","unstructured":"Casanova NA, Redondo LM, Dailoff GC, Arenas D, Fern\u00e1ndez Miyakawa ME (2018) Overview of the role of Shiga toxins in porcine edema disease pathogenesis. Toxicon 148:149\u2013154","journal-title":"Toxicon"},{"key":"1161_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3201\/eid0605.000503","volume":"6","author":"PT Kimmitt","year":"2000","unstructured":"Kimmitt PT, Harwood CR, Barer MR (2000) Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis 6:458\u2013465","journal-title":"Emerg Infect Dis"},{"key":"1161_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1292\/jvms.16-0471","volume":"79","author":"R Uemura","year":"2017","unstructured":"Uemura R, Katsuge T, Sasaki Y, Goto S, Sueyoshi M (2017) Effects of zinc supplementation on Shiga toxin 2e-producing Escherichia coli in vitro. J Vet Med Sci 79:1637\u20131643","journal-title":"J Vet Med Sci"},{"key":"1161_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1128\/iai.60.2.485-490.1992","volume":"60","author":"VM Gordon","year":"1992","unstructured":"Gordon VM, Whipp SC, Moon HW, O\u2019Brien AD, Samuel JE (1992) An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun 60:485\u2013490","journal-title":"Infect Immun"},{"key":"1161_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1128\/iai.64.1.55-60.1996","volume":"64","author":"BT Bosworth","year":"1996","unstructured":"Bosworth BT, Samuel JE, Moon HW, O\u2019Brien AD, Gordon VM, Whipp SC (1996) Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infect Immun 64:55\u201360","journal-title":"Infect Immun"},{"key":"1161_CR6","first-page":"280","volume":"61","author":"M Johansen","year":"1997","unstructured":"Johansen M, Andresen LO, Jorsal SE, Thomsen LK, Waddell TE, Gyles CL (1997) Prevention of edema disease in pigs by vaccination with verotoxin 2e toxoid. Can J Vet Res 61:280\u2013285","journal-title":"Can J Vet Res"},{"key":"1161_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1128\/IAI.05539-11","volume":"80","author":"TK Oanh","year":"2012","unstructured":"Oanh TK, Nguyen VK, De Greve H, Goddeeris BM (2012) Protection of piglets against Edema disease by maternal immunization with Stx2e toxoid. Infect Immun 80:469\u2013473","journal-title":"Infect Immun"},{"key":"1161_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0378-1135(91)90138-6","volume":"29","author":"DL MacLeod","year":"1991","unstructured":"MacLeod DL, Gyles CL (1991) Immunization of pigs with a purified Shiga-like toxin II variant toxoid. Vet Microbiol 29:309\u2013318","journal-title":"Vet Microbiol"},{"key":"1161_CR9","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1128\/iai.58.5.1232-1239.1990","volume":"58","author":"DL MacLeod","year":"1990","unstructured":"MacLeod DL, Gyles CL (1990) Purification and characterization of an Escherichia coli Shiga-like toxin II variant. Infect Immun 58:1232\u20131239","journal-title":"Infect Immun"},{"key":"1161_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1006\/mpat.1993.1006","volume":"14","author":"DW Acheson","year":"1993","unstructured":"Acheson DW, Jacewicz M, Kane AV, Donohue-Rolfe A, Keusch GT (1993) One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays. Microb Pathog 14:57\u201366","journal-title":"Microb Pathog"},{"key":"1161_CR11","first-page":"681","volume":"3","author":"JH Doughari","year":"2009","unstructured":"Doughari JH, Ndakidemi PA, Human IS, Bennade S (2009) Shiga toxins (Verocytotoxins). Afr J Microbiol Res 3:681\u2013693","journal-title":"Afr J Microbiol Res"},{"key":"1161_CR12","doi-asserted-by":"publisher","first-page":"22346","DOI":"10.1016\/S0021-9258(18)41677-8","volume":"267","author":"A Oldberg","year":"1992","unstructured":"Oldberg A, Antonsson P, Lindblom K, Heineg\u00e5rd D (1992) COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 267:22346\u201322350","journal-title":"J Biol Chem"},{"key":"1161_CR13","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1016\/j.vaccine.2014.07.016","volume":"32","author":"T Arakawa","year":"2014","unstructured":"Arakawa T, Harakuni T (2014) Cholera toxin B subunit-five-stranded \u03b1-helical coiled-coil fusion protein: \u201cfive-to-five\u201d molecular chimera displays robust physicochemical stability. Vaccine 32:5019\u20135026","journal-title":"Vaccine"},{"key":"1161_CR14","unstructured":"Act on Welfare and Management of Animals (Act No. 105 of October 1, 1973) https:\/\/www.env.go.jp\/nature\/dobutsu\/aigo\/1_law\/files\/aigo_kanri_1973_105_en.pdf. Accessed 12 Sept 2022"},{"key":"1161_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1292\/jvms.67.1167","volume":"67","author":"T Tsukahara","year":"2005","unstructured":"Tsukahara T, Nakanishi N, Nakayama K, Matsubara N, Ushida K (2005) Experimental infection of enterotoxemic Escherichia coli associated with porcine edema disease and its pathologic characteristics in the intestine. J Vet Med Sci 67:1167\u201311671","journal-title":"J Vet Med Sci"},{"key":"1161_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1292\/jvms.13-0118","volume":"75","author":"T Sato","year":"2013","unstructured":"Sato T, Matsui T, Takita E, Kadoyama Y, Makino S, Kato K,\u00a0Sawada K, Hamabata T\u00a0(2013) Evaluation of recombinant forms of the Shiga toxin variant Stx2eB subunit and non-toxic mutant Stx2e as vaccine candidates against porcine edema disease. J Vet Med Sci 75:1309\u20131315","journal-title":"J Vet Med Sci"},{"key":"1161_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1128\/iai.63.1.301-308.1995","volume":"63","author":"DWK Acheson","year":"1995","unstructured":"Acheson DWK, De Breucker SA, Jacewicz M, Lincicome LL, Donohue-Rolfe A, Kane AV, Keusch GT (1995) Expression and purification of Shiga-like toxin II B subunits. Infect Immun 63:301\u2013308","journal-title":"Infect Immun"},{"key":"1161_CR18","unstructured":"Yokogawa K, Waki T, Honda Y, Uefuji H, Sewaki T, Arakawa T, Harakuni T and Miyata T. Vaccine for preventing porcine edema disease. Patent: PCT\/JP2013\/078305. https:\/\/patents.google.com\/patent\/WO2014065210A1\/en. Accessed 12 Sept 2022"},{"key":"1161_CR19","first-page":"331","volume":"52","author":"VPJ Gannon","year":"1988","unstructured":"Gannon VPJ, Gyles CL, Friendship RW (1988) Characteristics of verotoxigenic Escherichia coli from pigs. Can J Vet Res 52:331\u2013337","journal-title":"Can J Vet Res"},{"key":"1161_CR20","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1128\/iai.64.5.1879-1883.1996","volume":"64","author":"RP Johnson","year":"1996","unstructured":"Johnson RP, Cray WC Jr, Johnson ST (1996) Serum antibody responses of cattle following experimental infection with Escherichia coli O157:H7. Infect Immun 64:1879\u20131883","journal-title":"Infect Immun"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-023-01161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-023-01161-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-023-01161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T13:08:20Z","timestamp":1679922500000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryresearch.biomedcentral.com\/articles\/10.1186\/s13567-023-01161-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1186\/s13567-023-01161-1","relation":{},"ISSN":["1297-9716"],"issn-type":[{"type":"electronic","value":"1297-9716"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical trial was conducted following the GCP Guidelines, in compliance with the \u201cAct on Welfare and Management of Animals\u201d, and according to the guidelines of the KYODOKEN Institute (Approval number: CS142071, KYODOKEN 3169) for animal studies. In addition, the trial was conducted with the consent of the owner of Asagiri Farm, who owns the animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}